Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | AR | P10275 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 8/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | SELL | P14151 | 3/20 | 0.40 |
| ▸ | SELP | P16109 | 3/20 | 0.40 |
| ▸ | SELE | P16581 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24239553 | 0.96 | MAPK1 (0.52) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL17519160 | 0.96 | MAPK1 (0.52) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL24239556 | 0.96 | MAPK1 (0.52) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL15711575 | 0.95 | GLP1R (0.53) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL24239566 | 0.95 | GLP1R (0.53) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL17519200 | 0.95 | GLP1R (0.53) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL24239564 | 0.95 | GLP1R (0.53) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL15702040 | 0.95 | GLP1R (0.53) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL16920715 | 0.94 | ESR1 (0.47) | ESR1PGRHTR1AADORA3AR | |
| SCHEMBL20285786 | 0.93 | ESR1 (0.49) | ESR1PGRHTR1AADORA3AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150368642-A1 | LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368642-A1 | LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES | SLC5A1, CSGALNACT1, SLC5A2 | ESR1 2091/4885PGR 4442/4885HTR1A 4842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.